EUVIMEDEUVIMED entdecken
Scoping Review

Radiation recall dermatitis in cancer patients previously undergoing radiotherapy: a scoping review

Paloma Gomes, Amanda Gomes de Menêses, Renata Cristina de Campos Pereira Silveira, Eliete Neves Silva Guerra, Paula Elaine Diniz Dos Reis, Elaine Barros Ferreira

Supportive Care in Cancer · 2026-01 · 34 (1)

DOI: 10.1007/s00520-025-10222-4 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Supportive Care in Cancer, online erschienen am 11.12.2025. Verfasst von Paloma Gomes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences. Interdisciplinary Research Laboratory Applied to Clinical Practice in Oncology - LIONCO, University of Brasília, Campus D…. Hauptthemen laut MEDLINE: Radiodermatitis, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 222 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To map the evidence related to radiation recall dermatitis (RRD) in cancer patients previously treated with radiotherapy. METHODS: A scoping review was conducted following the methodology outlined by the JBI Collaboration. The search was performed in PubMed, CINAHL, LILACS, Scopus, Web of Science Core Collection, Cochrane, and grey literature using Google Scholar and ProQuest on January 28, 2025. Studies published in any language and without restrictions on publication year were included. RESULTS: This review incorporated 210 studies on RRD in cancer patients, with a predominance of case reports and case series (84.7%). Approximately 48% of cases were reported in breast cancer patients. Among these studies, 92 primary articles documented 201 instances of RRD. A significant association was identified with antineoplastic agents (73.6%), predominantly due to chemotherapy, with docetaxel identified as the most frequently reported agent (13.5%). The radiotherapy doses administered ranged from 8 to 65 Grays, and the time intervals between radiotherapy and the onset of the RRD-triggering agent varied widely, from hours to 40 years. This condition can cause symptoms such as erythema, dry and moist desquamation, edema, itching, pain, ulceration, necrosis, and bleeding. CONCLUSION: RRD is a significant adverse event, particularly among women with breast cancer, most commonly associated with chemotherapy involving docetaxel and doxorubicin. COVID-19 infection and vaccination have also been reported as potential new triggers of RRD. Further research is needed to clarify the underlying mechanisms and to optimize therapeutic strategies for at-risk patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiodermatitisNeoplasmsHumansAntineoplastic AgentsFemaleRadiotherapy

Stichwörter der Autor:innen

Antineoplastic agentsNeoplasmsRadiodermatitisRadiotherapyScoping review

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Faculty of Health Sciences. Interdisciplinary Research Laboratory Applied to Clinical Practice in Oncology - LIONCO, University of Brasília, Campus Darcy Ribeiro, Asa Norte, Brasília, DF, 70910-900, Brazil.
  • Centro Universitário UDF, SEP SUL, EQ 704/904, Conj. A - Asa Sul, Brasília, DF, 70390-045, Brazil.
  • General and Specialized Nursing Department, Ribeirão Preto College of Nursing, WHO Collaborating Centre for Nursing Research Development, University of São Paulo, Bandeirantes Avenue, 3900. Campus - Monte Alegre, Ribeir…
  • Faculty of Health Sciences. Interdisciplinary Research Laboratory Applied to Clinical Practice in Oncology - LIONCO, University of Brasília, Campus Darcy Ribeiro, Asa Norte, Brasília, DF, 70910-900, Brazil. elainebf@unb…

Zitieren

APA

Gomes, P., de Menêses, A. G., Silveira, R. C. C. P., Guerra, E. N. S., Dos Reis, P. E. D., & Ferreira, E. B. (2026). Radiation recall dermatitis in cancer patients previously undergoing radiotherapy: a scoping review. Supportive Care in Cancer, 34(1). https://doi.org/10.1007/s00520-025-10222-4

Vancouver

Gomes P, de Menêses AG, Silveira RCCP, Guerra ENS, Dos Reis PED, Ferreira EB. Radiation recall dermatitis in cancer patients previously undergoing radiotherapy: a scoping review. Supportive Care in Cancer. 2026;34(1). doi:10.1007/s00520-025-10222-4

BibTeX
@article{Gomes2026,
  author = {Gomes, Paloma and de Menêses, Amanda Gomes and Silveira, Renata Cristina de Campos Pereira and Guerra, Eliete Neves Silva and Dos Reis, Paula Elaine Diniz and Ferreira, Elaine Barros},
  title = {Radiation recall dermatitis in cancer patients previously undergoing radiotherapy: a scoping review},
  journal = {Supportive Care in Cancer},
  year = {2026},
  volume = {34},
  number = {1},
  doi = {10.1007/s00520-025-10222-4}
}
Kostenlos starten →